- Home
- FSTR vs AQST Comparison
FSTR vs AQST Comparison
Compare FSTR & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSTR
- AQST
- Stock Information
- Founded
- FSTR 1902
- AQST 2004
- Country
- FSTR United States
- AQST United States
- Employees
- FSTR N/A
- AQST N/A
- Industry
- FSTR Metal Fabrications
- AQST Biotechnology: Pharmaceutical Preparations
- Sector
- FSTR Industrials
- AQST Health Care
- Exchange
- FSTR Nasdaq
- AQST Nasdaq
- Market Cap
- FSTR 219.6M
- AQST 274.4M
- IPO Year
- FSTR N/A
- AQST 2018
- Fundamental
- Price
- FSTR $20.50
- AQST $2.75
- Analyst Decision
- FSTR Hold
- AQST Strong Buy
- Analyst Count
- FSTR 1
- AQST 7
- Target Price
- FSTR $25.00
- AQST $10.57
- AVG Volume (30 Days)
- FSTR 50.3K
- AQST 1.5M
- Earning Date
- FSTR 03-04-2025
- AQST 03-05-2025
- Dividend Yield
- FSTR N/A
- AQST N/A
- EPS Growth
- FSTR 2892.31
- AQST N/A
- EPS
- FSTR 3.89
- AQST N/A
- Revenue
- FSTR $530,765,000.00
- AQST $57,561,000.00
- Revenue This Year
- FSTR $10.37
- AQST N/A
- Revenue Next Year
- FSTR $4.98
- AQST $35.72
- P/E Ratio
- FSTR $5.25
- AQST N/A
- Revenue Growth
- FSTR N/A
- AQST 13.80
- 52 Week Low
- FSTR $14.23
- AQST $2.24
- 52 Week High
- FSTR $30.77
- AQST $6.23
- Technical
- Relative Strength Index (RSI)
- FSTR 30.25
- AQST 45.85
- Support Level
- FSTR $19.52
- AQST $2.45
- Resistance Level
- FSTR $20.80
- AQST $2.91
- Average True Range (ATR)
- FSTR 1.20
- AQST 0.20
- MACD
- FSTR -0.26
- AQST 0.03
- Stochastic Oscillator
- FSTR 11.84
- AQST 49.18
About FSTR L.B. Foster Company
L.B. Foster Co is a us-based firm engaged in the manufacturing, fabrication, and distribution of products and services, especially for the rail, construction, energy, and utility industries. The company operates its business through two segments: Rail Technologies and Services and Infrastructure Solutions. Its principal business activity involves providing new and used rail, trackwork, and accessories, producing concrete railroad ties, insulated rail joints, power rail, track fasteners, cover boards, and sales of sells and rents steel sheet piling, H-bearing pile, and other piling products for foundation and earth retention requirements. It generates the majority of its revenues from the Rail Technologies and Services segment.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.